Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹230Prev. Close
₹222Turnover(Lac.)
₹55.88Day's High
₹232Day's Low
₹21552 Week's High
₹24752 Week's Low
₹131Book Value
₹45.81Face Value
₹10Mkt Cap (₹ Cr.)
249.07P/E
35.33EPS
6.13Divi. Yield
012 Aug 2023
12:00 AM
AGM
Announcement Date: 12 Aug, 2023
16 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
12 Aug 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 11.5 | 8 | 5 | 3.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 34.13 | -3.22 | -5.47 | -6.1 |
Net Worth | 45.63 | 4.78 | -0.47 | -3 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
Gross Sales | 44.63 | 31.69 | 21.77 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 44.63 | 31.69 | 21.77 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 2.08 | 1.16 | 0.6 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,525.5 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,542.75 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,482.5 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,092.3 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,457.55 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Hardik J Desai
Whole Time Director & CFO
Mayurkumar Mansukhbhai Gajera
Managing Director
Shravan Harikrishna Patel
Non Executive Director
Maniya H Desai
Independent Director
Aena Surana
Independent Director
Mishal Shailesh Patel
Company Sec. & Compli. Officer
Jiteshkumar Ramchandra Varkal
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Trident Lifeline Ltd
Summary
Trident Lifeline Limited was originally incorporated as Private Limited Company under the name Trident Lifeline Private Limited on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders Resolution on June 02, 2022 and name of Company was changed to Trident Lifeline Limited on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It operate in India as well as African, Latin American and East Indian Countries. Presently, it has presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venezuela.Presently, Company operates with one contract manufacturer, who maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under their own brands. Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. The Company typically work on contract manufacturing basis or at
Read More
What is the Trident Lifeline Ltd share price today?
The Trident Lifeline Ltd shares price on nse is Rs.₹216.6 today.
What is the Market Cap of Trident Lifeline Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Trident Lifeline Ltd is ₹249.07 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Trident Lifeline Ltd?
The PE and PB ratios of Trident Lifeline Ltd is 35.33 and 4.73 as of 03 Jul ‘24
What is the 52 Week High and Low of Trident Lifeline Ltd?
The 52-week high/low is the highest and lowest price at which a Trident Lifeline Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Trident Lifeline Ltd is ₹131 and ₹247 as of 03 Jul ‘24
What is the CAGR of Trident Lifeline Ltd?
Trident Lifeline Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 58.57%, 6 Month at 19.45%, 3 Month at 38.75% and 1 Month at 37.04%.
What is the shareholding pattern of Trident Lifeline Ltd?
The shareholding pattern of Trident Lifeline Ltd is as follows:
Promoters - 67.48 %
Institutions - 6.02 %
Public - 26.50 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
